NCT05840224 2026-01-28
Study of GS-4528 in Adults With Solid Tumors
Gilead Sciences
Phase 1 Active not recruiting
Clinical Trials
8 trialsNCT05007782 2025-12-29
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
Gilead Sciences
Phase 1 Recruiting
NCT06082960 2025-09-10
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
Gilead Sciences
Phase 1 Active not recruiting
NCT06532565 2025-05-16
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
Gilead Sciences
Phase 1 Recruiting
NCT03628677 2025-02-04
A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies
Arcus Biosciences, Inc.
Phase 1 Completed
NCT04087018 2024-09-19
Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors
Arcus Biosciences, Inc.
Phase 1 Completed
NCT04747470 2024-09-03
Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors
Gilead Sciences
Phase 1 Terminated
NCT05909436 2023-06-18
Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
Guangzhou Gloria Biosciences Co., Ltd.
Phase 1/2 Recruiting